If the UK has blinked on pharmaceutical pricing, Australia might have to pay attention

October 2, 2025 Latest News BioPharma News of the Day

This is a preview of subscriber content

Subscribe now to continue reading.

While the UK has agreed to negotiate higher pharmaceutical prices, Pfizer's agreement with the Trump administration suggests a willingness to compromise and limit its domestic MFN demand to some government programs. …

Subscribe now to continue reading.

Latest Video

Reforming the institutional framework is the only pathway to fairness
September 30, 2025 - Latest News
Lower than expected uptake of new therapies impacts PBS spend
September 29, 2025 - Latest News
New pricing dynamics emerging for Australia as Pfizer signs up to US 'MFN'
October 1, 2025 - Latest News
Is a new listing another test for PBS biosimilar policy?
October 1, 2025 - Latest News
The symptoms have been identified, but the widely held belief about the cause is a miss
September 30, 2025 - Latest News

If the UK has blinked on pharmaceutical pricing, Australia might have to pay attention

This is a preview of subscriber content

Latest Video

Most Read

Reforming the institutional framework is the only pathway to fairness

Lower than expected uptake of new therapies impacts PBS spend

New pricing dynamics emerging for Australia as Pfizer signs up to US 'MFN'

Is a new listing another test for PBS biosimilar policy?

The symptoms have been identified, but the widely held belief about the cause is a miss

New Stories

If the UK has blinked on pharmaceutical pricing, Australia might have to pay attention

Rising influenza deaths spark call for nurse-led vaccination clinics

Radiopharm Theranostics accelerates HER2 cancer trial after positive safety review

dorsaVi achieves breakthrough in robotic reflex intelligence

New Zealand resets medical device procurement after years of paralysis

INOVIQ publishes breakthrough data on next-generation cancer therapy

Cancer vaccine collaboration lands on the Gold Coast

Sign In

If the UK has blinked on pharmaceutical pricing, Australia might have to pay attention

This is a preview of subscriber content

Latest Video

Most Read

Reforming the institutional framework is the only pathway to fairness

Lower than expected uptake of new therapies impacts PBS spend

New pricing dynamics emerging for Australia as Pfizer signs up to US 'MFN'

Is a new listing another test for PBS biosimilar policy?

The symptoms have been identified, but the widely held belief about the cause is a miss

Follow Us

New Stories

If the UK has blinked on pharmaceutical pricing, Australia might have to pay attention

Rising influenza deaths spark call for nurse-led vaccination clinics

Radiopharm Theranostics accelerates HER2 cancer trial after positive safety review

dorsaVi achieves breakthrough in robotic reflex intelligence

New Zealand resets medical device procurement after years of paralysis

INOVIQ publishes breakthrough data on next-generation cancer therapy

Cancer vaccine collaboration lands on the Gold Coast